Mirabegron has emerged as a preferred choice in urology treatment not only due to its efficacy but also because it addresses the limitations of conventional therapies. Unlike antimuscarinic drugs that often cause dry mouth, constipation, and blurred vision, Mirabegron provides a targeted approach, offering patients a safer and more comfortable treatment experience. This unique advantage has accelerated its adoption in both developed and emerging pharmaceutical markets.
Furthermore, the growing prevalence of urinary disorders, especially among the aging population, has fueled the demand for innovative therapies like Mirabegron. As healthcare providers increasingly focus on patient-centric treatments, the Mirabegron API has become a cornerstone in developing effective medications for Overactive Bladder (OAB) and Neurogenic Detrusor Overactivity (NDO). Its success story highlights the importance of high-quality APIs in ensuring consistent therapeutic outcomes.
What is the mechanism of Mirabegron API?
Mirabegron API gained popularity as one of the best bladder treatment APIs because of its mechanism of targeting the beta-3 adrenergic receptors. The API stimulates the receptors, causing the smooth muscles of the urinary bladder to relax. It reduces the frequent urge to urinate and helps the urinary bladder hold more urine.
What is the use of Mirabegron?
The Mirabegron API is used to create drugs for urinary disorders and is used for treating the following two conditions. Overactive bladder (OAB) Overactive Bladder (OAB) is a condition characterized by the loss of control of the urinary bladder. It results in frequent urination, the urge to urinate even when the bladder is not full, or incontinence. It has become a common condition in many adults. Mirabegron is used as the first treatment for OAB by 67% of healthcare professionals instead of the anticholinergic drugs(source). If patients don't find effective results, doctors often use Mirabegron and Solifenacin together for better results.
Neurogenic Detrusor Overactivity (NDO)
Neurogenic Detrusor Overactivity is when the bladder becomes overactive due to neurological conditions, such as Multiple Sclerosis (MS) and spinal injury. Like the OAB, the patients with NDO also experience frequent urges to urinate, incontinence, and lack of bladder control. Mirabegron helps reduce contractions and regulates urinary bladder activities. As per a study, 73% of patients with NDO saw a positive impact of Mirabegron, and the number of patients decreased from 60.3% to 38.1% (source).
How to consume Mirabegron for urology treatment?
There are two pharmaceutical forms of Mirabegron used for treating urology conditions, the OAB and NDO, as mentioned below.
- Oral tablet: The tablets are allowed whole with water and not crushed or chewed. An adult patient can consume it before or after food intake as per the doctor's guidance. However, for kids, it's better to be consumed after food intake.
- Oral liquid (suspension): The Mirabegron granules are used to create an oral suspension for urology treatment. The solution can be used for 28 days only. Store the bottle away from sunlight and shake it well before use to ensure uniform suspension.
What are the side effects of Mirabegron?
Mirabegron is known for its minimal side effects, but there are still some side effects that you must know. The following are a few common side effects some patients experience after consuming Mirabegron.
- Hypertension (high blood pressure)
- Infection in the nose and throat
- Kidney infection
- Constipation
- Headache
- Angioedema allergic reaction
Precautions for Mirabegron treatment If you have a medical condition, you must discuss it with your doctor before starting the Mirabegron treatment. A rise in blood pressure is a common side effect of the drug. Therefore, heart patients are advised to avoid this medicine.
The following is the list of people who should use Mirabegron with caution for urology treatment:
- Heart patients
- Kidney problem patients
- Liver problem patients
If you experience urine blockage, immediately stop taking Mirabegron and contact your healthcare provider. Chemox Pharma: Trusted Mirabegron API supplier Chemox Pharma is a trusted manufacturer of Mirabegron Intermediates and APIs for urology treatment drugs. Our state-of-the-art manufacturingunit at Dahej is equipped with high-end technology and a team of skilled scientists and lab technicians to create effective and safe APIs and intermediates.
We can help you create the Mirabegron API in your desired IH, BP, USP, IP, and EP standards. We can help you create custom packaging that fits your needs. Contact us now with your queries.
For pharmaceutical companies looking to develop reliable urology treatments, partnering with a trusted API supplier is critical. Chemox Pharma's commitment to quality, advanced technology, and strict adherence to global standards ensures that every batch of Mirabegron API meets the highest benchmarks of safety and efficacy. By sourcing APIs from Chemox Pharma, manufacturers can confidently produce medications that deliver consistent results to patients worldwide.
With a focus on innovation, precision, and customer satisfaction, Chemox Pharma continues to support the growing urology treatment market. Whether it's providing Mirabegron APIs in various pharmacopeia standards or offering customized packaging solutions, Chemox Pharma stands as a reliable partner for pharmaceutical companies aiming to make a significant impact in patient care and treatment efficiency.
Sign in to leave a comment.